This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1‐γ ELISA results: Comment on "Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody". Issue 1 (29th September 2022)
Record Type:
Journal Article
Title:
A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1‐γ ELISA results: Comment on "Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody". Issue 1 (29th September 2022)
Main Title:
A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1‐γ ELISA results: Comment on "Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody"